Litcius/Paper detail

Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study

André Rodrigues Durães, Yasmin de Souza Lima Bitar, Igor Schonhofen, Kethyren Santos Oliveira Travassos, Larissa Vitória Pereira, José Admirço Lima Filho, Mansueto Gomes Neto, Roque Aras, Leonardo Roever

2020American Journal of Cardiovascular Drugs54 citationsDOI

Topics & Concepts

RivaroxabanMedicineWarfarinDiscontinuationAtrial fibrillationMyocardial infarctionRandomized controlled trialStroke (engine)SurgeryVitamin K antagonistInternal medicineAnesthesiaEngineeringMechanical engineeringAtrial Fibrillation Management and OutcomesCardiac Valve Diseases and TreatmentsCardiac tumors and thrombi
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study | Litcius